Topics

Novartis' legelizumab outperforms Roche's Xolair in chronic urticaria clearance: http://bit.ly/2M0yUrM  #pharmapic.twitter.com/Zvam5VOX9h

14:00 EDT 9 Oct 2019 | Pharmafile

Novartis' legelizumab outperforms Roche's Xolair in chronic urticaria clearance: http://bit.ly/2M0yUrM 

Original Article: Novartis' legelizumab outperforms Roche's Xolair in chronic urticaria clearance: http://bit.ly/2M0yUrM  #pharmapic.twitter.com/Zvam5VOX9h

NEXT ARTICLE

More From BioPortfolio on "Novartis' legelizumab outperforms Roche's Xolair in chronic urticaria clearance: http://bit.ly/2M0yUrM  #pharmapic.twitter.com/Zvam5VOX9h"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...